That's what I thought.
Fiona Woods was doing the trial, and the trial would be done entirely on their terms.
Recce had no control, and could only sit back and wait for any results.
If Fiona Woods did not get the required patients to sign up, they couldn't do an effective trial, so they called off the trial. Fair call, I have no issue with that.
I have no problem holding this stock, and I appreciate that, although there are occasionally some exciting announcements, this is a waiting game.
In my view, Sepsis is, and always has been, the main game.
RCE Price at posting:
70.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)